Why Plug Power, Varonis Systems, and Galectin Therapeutics Are Today's 3 Best Stocks

It was another day of mixed data for the broad-based S&P 500 (SNPINDEX: ^GSPC  ) , but this time investors were able to look past recent housing weakness and latch on to improved consumer outlooks.

The big driver today was the Conference Board's final consumer confidence reading for March, which at 82.3 marks a six-year high. This improvement from a prior reading of 78.3 moves us decisively past the winter swoon that brought confidence levels down and signals that consumers are considerably more optimistic about their short-term and long-term financial outlooks. This reading is noteworthy since consumer spending accounts for roughly 70% of U.S. GDP.

On the flip side, housing data continued to be a modest disappointment. Although the Case-Shiller 20-city index showed a 13.2% year-over-year improvement in home prices thanks to tight inventory controls from America's top homebuilders, new homes sales fell by more than 3% in February to a seasonally adjusted annual rate of 440,000. There's only so much inventory tightening that homebuilders can do before volume begins to outweigh higher prices and negatively affects their bottom line.

By day's end the S&P 500 put its two-day losing streak in the rearview mirror and pushed decisively higher by 8.18 points (0.44%) to close at 1,865.62.

Source: Plug Power.

Leading the pack higher today was highly polarizing fuel-cell systems developer Plug Power (NASDAQ: PLUG  ) . which exploded to the upside by 49% after CEO Andy Marsh told MarketWatch in a telephone interview on Tuesday that the company had signed an additional order with a global automaker that should be announced in the next two to three weeks. The report also noted that Plug Power anticipates landing another GenKey deal this year similar to the one it signed with Wal-Mart earlier to supply 1,738 fuel-cell systems for forklifts in six regional warehouses. While I continue to applaud Plug Power for validating its technology through these large deals, I very much believe that shareholders are counting their chickens before they're hatched. We have no details about this auto deal and Plug still isn't profitable on a trailing basis. I'd much prefer to wait for these uncertainties to clear before even considering it a viable investment.

Varonis Systems (NASDAQ: VRNS  ) , which makes software that enables businesses to manage and analyze their unstructured data, gained 19.9% after the expiration of the lockup period allowed five research firms to initiate coverage on the company. In total, Varonis received three buy rating equivalents from RBC Capital, Needham, and Jefferies, which respectively initiated price targets of $50, $48, and $45. As a reminder, Varonis' shares closed yesterday at just $36.51. It also received two ratings that were the equivalent of a hold from Morgan Stanley and Barclays. I personally tend to fall more in line with Morgan Stanley and Barclays in that I recognize the high-growth opportunity afforded to Varonis, but believe profit may be a ways off as it sacrifices bottom-line gains for research and development and expansion.

Source: Galectin Therapeutics.

Lastly, clinical-stage biopharmaceutical company Galectin Therapeutics (NASDAQ: GALT  ) jumped 8.8% after issuing a press release noting that it would announce the first part of its phase 1 results for GR-MD-02 in patients with nonalcoholic steatohepatitis, or NASH, with advanced fibrosis on Monday, March 31. The press release noted that CEO Peter Traber would hold a webcast to discuss the results the following day. Investors have to be thinking here that the data is positive, otherwise it seems very unlikely that Galectin would schedule a webcast. All eyes are on GR-MD-92, since NASH is a widespread disease estimated to affect 6 million people in its most severe form. But this phase 1 data is merely based on safety and biomarker identification and is unlikely to reveal much in the way of drug efficacy. Shareholders would be best suited sticking to the sidelines until we have more concrete efficacy data from later-stage studies.

Plug Power, Varonis Systems, and Galectin may have soared today, but they'll likely be hard-pressed to keep up with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (3) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 26, 2014, at 8:11 AM, Hilow wrote:

    Plug's order announcement has been clarified by it's media dept. via Schnectady NY's "Daily Gazette". The auto order is for fork lifts and not fuel cells for cars. One has to believe that all these publications with stock advice had to have been privy to that info if not the auto company's name but omitted it from their releases.

  • Report this Comment On March 26, 2014, at 9:09 AM, caliwoah wrote:

    Yes it has been clarified, although it seems as if who ever wrote that article didn't put much research into the stock, PLUG's all time high was NOT $11.27,

    it was $1565.00. - years ago, but all the same, please aim for accurate information.

    also, plug offers a transition service from battery block to fuel cell, not only via forklifts and machinery, but in every real world scenario. This - leaving its potential limitless and practical for companies afraid to make the change.

    for the first time in years PLUG shows potential for growth. I'm glad companies like Wallmart are leading the way.

  • Report this Comment On March 26, 2014, at 9:19 AM, merlej1934 wrote:

    can you trust the fool?

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2889897, ~/Articles/ArticleHandler.aspx, 9/4/2015 8:40:03 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and in investment planning topics. You'll usually find him writing about Obamacare, marijuana, developing drugs, diagnostics, and medical devices, Social Security, taxes, or any number of other macroeconomic issues.

Today's Market

updated 11 hours ago Sponsored by:
DOW 16,374.76 23.38 0.14%
S&P 500 1,951.13 2.27 0.12%
NASD 4,733.50 0.00 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/3/2015 4:35 PM
^GSPC $1951.13 Up +2.27 +0.12%
S&P 500 INDEX CAPS Rating: No stars
GALT $2.06 Down +0.00 +0.00%
Galectin Therapeut… CAPS Rating: *
PLUG $1.69 Down +0.00 +0.00%
Plug Power, Inc. CAPS Rating: *
VRNS $19.96 Down +0.00 +0.00%
Varonis Systems, I… CAPS Rating: No stars